About
About Professor Majid
Professor and Chair of Cerebrovascular Neurology, University of Sheffield — translating cutting-edge neuroscience into effective therapies for stroke and cerebrovascular disease.
Professor Arshad Majid is Professor and Chair of Cerebrovascular Neurology in the School of Medicine and Population Health at the University of Sheffield, an Honorary Consultant Neurologist at the Sheffield Teaching Hospitals NHS Foundation Trust (Royal Hallamshire Hospital), and Director of the Comprehensive Cerebrovascular Research Unit. In 2025 he was appointed an NIHR Senior Investigator.
His career bridges bench science and bedside care — from medical graduation at the University of Glasgow and neurology training at the University of Pennsylvania, to founding the Division of Cerebrovascular Diseases at Michigan State University and the William & Claire Dart Stroke Center at Sparrow Health System, before joining Sheffield in 2013.
“My professional mission is to translate cutting-edge neuroscience into effective therapies for patients with cerebrovascular and other neurological diseases.” — Professor Arshad Majid
About
Professor Majid is an international clinician-scientist and translational stroke leader developing disease-modifying therapies for cerebrovascular disease and brain repair. He leads large-scale translational programmes spanning mechanistic discovery, platform development, and adaptive clinical trials, integrating neuroprotection, neuromodulation, and precision therapeutic strategies for stroke recovery and cerebral small vessel disease.
He has built nationally recognised stroke systems: at Michigan State University he established one of the first certified Comprehensive Stroke Centers in the US and founded an ACGME-accredited Vascular Neurology Fellowship; in the UK he served as Clinical Lead for the Stroke Research Network (Yorkshire and Humber), coordinating multicentre research across 12 institutions, and contributed to international consensus through the Stroke Treatment Academic Industry Roundtable (STAIR).
He is Chief Investigator of a Phase 3 adaptive trial of vagus nerve stimulation for post-stroke motor recovery (NIHR EME), and his early discoveries on lymphocyte cell kinase (Lck) in ischaemic preconditioning helped shape the field of stroke neuroprotection.
Education & Qualifications
- Medicine (MB ChB), University of Glasgow
- MRCP
- Neurology Residency, University of Pennsylvania — 2002
- Stroke research fellowship, Washington University in St. Louis — 1996 to 1998
- Interventional Neurology Fellowship, Medical College of Wisconsin — 2009
- Diplomate of the American Board of Psychiatry and Neurology
- Fellow and Regional Advisor of the Royal College of Physicians and Surgeons of Glasgow
Career
- Founding Director, Division of Cerebrovascular Diseases, Stroke and Interventional Neurology, Michigan State University and Sparrow Health System (Jul 2002 to 2011); Founding Director of the William and Clare Dart Stroke Center; Vascular Neurology Fellowship Director
- Academic Consultant Neurologist, Greater Manchester Neurosciences Centre — Jun 2011 to Aug 2013
- Joined the University of Sheffield and Royal Hallamshire Hospital in August 2013
- Director of the Comprehensive Cerebrovascular Research Unit (CCRU)
- Phase 3a Neurology Lead, Sheffield Medical School
- Head of Neurosciences — Mar 2022 to Jun 2024
- Deputy Dean, School of Medicine and Population Health — Aug 2023 to Jun 2024
- NIHR Senior Investigator — appointed 26 March 2025; one of 39 new Senior Investigators and a member of the NIHR Academy
Industry
Co-Founder and Head of Neuroscience, Midland Pharmaceuticals — Co-Founder since May 2024. Angel investor with a focus on technology, AI and healthcare.
Research Funding
Research funded by the NIH, American Heart Association, MRC, NIHR and industry.
Clinical & Academic Roles
- Professor and Chair of Cerebrovascular Neurology, University of Sheffield
- Honorary Consultant Neurologist, Royal Hallamshire Hospital
- Director, Comprehensive Cerebrovascular Research Unit
- NIHR Senior Investigator (2025)